EBITDA: Income before interest, taxes, depreciation and amortization.
Neurogene Inc. (NGNE) had EBITDA of $-27.24M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-24.73M |
|
-- |
|
-- |
|
$27.53M |
|
$-27.53M |
|
$2.79M |
|
$-24.73M |
|
$-24.73M |
|
$-24.73M |
|
$-24.73M |
|
$-24.73M |
|
$-24.73M |
|
$-27.53M |
|
|
EBITDA |
$-27.24M |
21.33M |
|
21.33M |
|
$-1.12 |
|
$-1.12 |
|
| Balance Sheet Financials | |
$271.77M |
|
$12.79M |
|
$16.83M |
|
$288.60M |
|
$16.41M |
|
$0.01M |
|
$7.31M |
|
$23.72M |
|
$264.89M |
|
$264.89M |
|
$264.89M |
|
15.49M |
|
| Cash Flow Statement Financials | |
$-77.17M |
|
$14.00M |
|
$30.43M |
|
$136.93M |
|
$104.18M |
|
$-32.74M |
|
$14.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.56 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-78.36M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.34% |
|
-9.34% |
|
-8.57% |
|
-9.34% |
|
$17.10 |
|
$-3.67 |
|
$-3.62 |
|